TrialDrugs in R&D2015

Biocomparison of Three Formulations of the S1P1 Receptor Modulator Ponesimod in Healthy Subjects.

Pierre-Eric Juif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.